Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth Conference



  AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth
  Conference

Canaccord Genuity Global Growth Conference 2013

Business Wire

CAMBRIDGE, Mass. -- August 9, 2013

AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief
financial officer, is scheduled to present at the Canaccord Genuity 33^rd
Annual Growth Conference on Thursday, August 15, 2013 at 2:00 p.m. (ET) in
Boston.

A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com. A
replay of the webcast will be archived on the AVEO website for two weeks
following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to
discovering, developing and commercializing targeted therapies to impact
patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the
company unique insights into cancer biology and is being leveraged in the
discovery and clinical development of its cancer therapeutics. For more
information, please visit the company’s website at www.aveooncology.com.

Contact:

AVEO Oncology
David Johnston, 617-299-5810
or
Pure Communications
Kristie Wallis, 336-774-8666
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement